Smith Shellnut Wilson LLC ADV Has $683,000 Stake in Colgate-Palmolive Company (CL)
Smith Shellnut Wilson LLC ADV trimmed its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 7.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,331 shares of the company’s stock after selling 725 shares during the quarter. Colgate-Palmolive makes up 0.7% of Smith Shellnut Wilson LLC ADV’s holdings, making the stock its 29th biggest holding. Smith Shellnut Wilson LLC ADV’s holdings in Colgate-Palmolive were worth $683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently modified their holdings of the company. American Beacon Advisors Inc. bought a new stake in Colgate-Palmolive in the first quarter worth approximately $102,000. Proficio Capital Partners LLC increased its holdings in Colgate-Palmolive by 16.9% in the first quarter. Proficio Capital Partners LLC now owns 1,432 shares of the company’s stock worth $107,000 after purchasing an additional 207 shares in the last quarter. Harbour Capital Advisors LLC bought a new stake in Colgate-Palmolive in the first quarter worth approximately $121,000. AlphaMark Advisors LLC increased its holdings in Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock worth $122,000 after purchasing an additional 1,370 shares in the last quarter. Finally, North Star Investment Management Corp. increased its holdings in Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after purchasing an additional 67 shares in the last quarter. Institutional investors own 73.10% of the company’s stock.
A number of equities research analysts have weighed in on the company. Macquarie assumed coverage on Colgate-Palmolive in a report on Thursday, September 14th. They issued a “neutral” rating and a $76.00 target price for the company. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Wednesday. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. Royal Bank Of Canada reiterated a “hold” rating and issued a $74.00 target price on shares of Colgate-Palmolive in a report on Thursday, May 25th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a report on Thursday, August 24th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $75.83.
In related news, SVP John J. Huston sold 14,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $71.36, for a total transaction of $999,040.00. Following the completion of the transaction, the senior vice president now owns 88,598 shares of the company’s stock, valued at approximately $6,322,353.28. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Vice Chairman Franck J. Moison sold 35,000 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $71.52, for a total value of $2,503,200.00. Following the transaction, the insider now directly owns 201,411 shares of the company’s stock, valued at approximately $14,404,914.72. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 217,969 shares of company stock valued at $15,693,933. 1.02% of the stock is owned by corporate insiders.
Colgate-Palmolive Company (CL) traded down 1.36% during midday trading on Thursday, hitting $71.56. The stock had a trading volume of 785,423 shares. The company has a market cap of $63.03 billion, a P/E ratio of 26.59 and a beta of 0.80. The firm’s 50-day moving average price is $71.58 and its 200 day moving average price is $73.27. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The company had revenue of $3.83 billion during the quarter, compared to analyst estimates of $3.89 billion. During the same quarter last year, the company earned $0.70 EPS. The firm’s revenue for the quarter was down .5% on a year-over-year basis. On average, analysts expect that Colgate-Palmolive Company will post $2.89 earnings per share for the current fiscal year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with MarketBeat.com's FREE daily email newsletter.